Status:

COMPLETED

A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)

Lead Sponsor:

AbbVie

Conditions:

Acute Myeloid Leukemia (AML)

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Acute Myeloid Leukemia (AML) is a cancer of the white blood cells which perform many functions, including fighting bacterial infections and defending the body against parasites. This study will evalua...

Eligibility Criteria

Inclusion

  • Confirmed diagnosis of AML, previously untreated, ineligible for intensive induction regimen due to age or co-morbidities.
  • Participants who are \>= 75 years of age or who are \>= 18 to 74 years of age with at least one of the following co-morbidities:
  • Eastern Cooperative Oncology Group (ECOG) performance status of 2 or 3.
  • Cardiac history of congestive heart failure requiring treatment or ejection fraction \<= 50% or chronic stable angina.
  • Diffusion capacity of lung for carbon monoxide (DLCO) \<= 65% or forced expiratory volume during the first second (FEV1) \<= 65%.
  • Adequate renal and hepatic criteria as described in the protocol.
  • Other co-morbidities that the physician judges to be incompatible with intensive chemotherapy must be reviewed and approved by the AbbVie Therapeutic Area Medical Director (TA MD) before study enrollment.

Exclusion

  • History of prior treatment for AML with the exception of hydroxyurea, allowed through the first cycle of study treatment.

Key Trial Info

Start Date :

October 5 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 15 2021

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT04509622

Start Date

October 5 2020

End Date

April 15 2021

Last Update

May 5 2022

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

NHO Nagoya Medical Center /ID# 223671

Nagoya, Aichi-ken, Japan, 460-0001

2

Aichi Cancer Center Hospital /ID# 223134

Nagoya, Aichi-ken, Japan, 464-8681

3

University of Fukui Hospital /ID# 223133

Yoshida-gun, Fukui, Japan, 910-1193

4

Kyushu University Hospital /ID# 223136

Fukuoka, Fukuoka, Japan, 812-8582